Noesis Capital Mangement Corp Gilead Sciences, Inc. Transaction History
Noesis Capital Mangement Corp
- $450 Billion
- Q1 2024
A detailed history of Noesis Capital Mangement Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Noesis Capital Mangement Corp holds 111,668 shares of GILD stock, worth $7.95 Million. This represents 1.82% of its overall portfolio holdings.
Number of Shares
111,668
Previous 106,445
4.91%
Holding current value
$7.95 Million
Previous $8.62 Billion
5.14%
% of portfolio
1.82%
Previous 2.03%
Shares
28 transactions
Others Institutions Holding GILD
# of Institutions
1,890Shares Held
1BCall Options Held
8.71MPut Options Held
8.02M-
Black Rock Inc. New York, NY123MShares$8.72 Billion0.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$8.17 Billion0.17% of portfolio
-
Capital World Investors Los Angeles, CA84.5MShares$6.01 Billion1.06% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.2MShares$4.36 Billion1.05% of portfolio
-
State Street Corp Boston, MA57.7MShares$4.11 Billion0.19% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $89.2B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...